 |
|
Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
Ji-Hee Yoon, Yunha Choi, Yena Lee, Han-Wook Yoo, Jin-Ho Choi
Ann Pediatr Endocrinol Metab. 2021;26(2):105-111. Published online 2021 Jun 30 DOI: https://doi.org/10.6065/apem.2040150.075
|
|
Citations to this article as recorded by
 Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density
Myeongseob Lee, Ahreum Kwon, Kyungchul Song, Hae In Lee, Han Saem Choi, Junghwan Suh, Hyun Wook Chae, Ho-Seong Kim
Annals of Pediatric Endocrinology & Metabolism.2024; 29(1): 46. CrossRef Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion
Xinggui Tian, Corina Vater, Deepak Bushan Raina, Lisa Findeisen, Lucas-Maximilian Matuszewski, Magnus Tägil, Lars Lidgren, Anja Winkler, Robert Gottwald, Niels Modler, Klaus-Dieter Schaser, Alexander C. Disch, Stefan Zwingenberger
Bioactive Materials.2024; 36: 256. CrossRef Bone health in inflammatory bowel disease
Hao Wei, Yihan Zhao, Lisha Xiang
Expert Review of Gastroenterology & Hepatology.2023; 17(9): 921. CrossRef Case Report and Literature Review: Bisphosphonate, Sirolimus, and Atenolol Treatment in a 4-Year-Old Child Diagnosed with Gorham–Stout Disease
Su Jin Park, Jae Won Yoo, Moon Bae Ahn
Pharmaceuticals.2023; 16(10): 1504. CrossRef Diagnosis and Management of Osteoporosis in Children and Adolescents
Hye Young Jin, Eu Seon Noh, Il Tae Hwang
The Ewha Medical Journal.2023;[Epub] CrossRef A Systematic Review and Meta Analysis of Non-Randomized Interventional Studies on the Pamidronate Treatment Efficacy for Patients with Bone Fibrous Dysplasia
Nicolas Daniel Widjanarko, Anthony Ekaputra, Jessica Felicia Ang
Siriraj Medical Journal.2023; 75(12): 851. CrossRef Risk Factors of Low Bone Mineral Density in Newly Diagnosed Pediatric Inflammatory Bowel Disease
Moon Bae Ahn, In Hyuk Yoo
Nutrients.2023; 15(24): 5048. CrossRef
|